Alexandra Collingbourne Alexandra Collingbourne

Eagle Genomics bolsters its senior team with 2 new appointments

Both deeply experienced in working with advanced life sciences technology, David Bennett joins as VP Commercial Operations and Sandra Bläser as VP of Customer Success, to satisfy strong demand for Eagle Genomics’ microbiome discovery platform as global brands strive to create sustainable next-gen products

Read More
Alexandra Collingbourne Alexandra Collingbourne

Prime Vision and Stamp Free sign strategic alliance

Computer vision integration specialist Prime Vision has signed a strategic alliance agreement with Stamp Free to support the rollout of the latter’s digital postage solution to existing and new postal clients worldwide.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Meet The U.K.’s Next 15 Unicorns

A near 10-fold increase in technology sector investment over the past decade has seen a dramatic increase in the number of unicorn companies valued at more than $1 billion in the U.K.—and dozens more are now poised to follow in their wake.

Read More
Alexandra Collingbourne Alexandra Collingbourne

The perfect EIS portfolio company? Introducing Nova Pangaea

Very simply, Nova Pangaea is a cleantech business that has created a revolutionary process to convert woody and agricultural plant residues into sustainable biocarbons, biopolymers, biochemicals and biofuels. It displaces the need for industry to use fossil based products.

Read More
Alexandra Collingbourne Alexandra Collingbourne

Eagle Genomics Adds 3 New US Advisory Board Members to its Global Panel

The successful British scale-up has attracted senior figures in international business development, pharmaceutical commercial strategy and nutrition innovation in San Diego, Cambridge Massachusetts, and New York to help shape the next phase of its worldwide growth.

Read More